For treatment-naïve and virologically suppressed adults with HIV-1. See Full Indication.

EDUCATIONAL RESOURCES

FOR DOVATO

EDUCATIONAL RESOURCES

FOR DOVATO

Prescribing Information

See the full Prescribing Information, including Boxed Warning, for DOVATO, an innovative approach with DTG at the core for treatment-naïve and virologically suppressed adult patients with HIV-1

Updated Guidelines

DHHS guidelines include updated recommendations

Hear From a Patient

Hear from a patient living with HIV-1 and learn more about DOVATO

Peer Perspective

Take a deeper dive into GEMINI data in this video with Dr. Lisa Capaldini, a paid consultant/speaker for ViiV Healthcare.

96-Week Data Video

Hear Dr. Benjamin Young, Head of Global Medical Directors for ViiV Healthcare, review 96-week data for DOVATO

Mechanism of Action Video

DOVATO inhibits the viral life cycle at 2 separate sites like a traditional 3-drug regimen

Power Reimagined Video

“I may be HIV positive… but my diagnosis does not define me.”

Interactive Quiz

Answer questions to test your familiarity with DOVATO. Upon completion, you’ll have a greater working knowledge of DOVATO

DHHS=Department of Health and Human Services; DTG=dolutegravir.

DLLWCNT200019